Resources for you and your patients
Here we've curated a collection of the most relevant links to help independent community pharmacies through the COVID-19 pandemic. Whether you need resources for communicating with patients or the latest guidance from the CDC and WHO, this is your destination for the most valuable coronavirus-related information, tools and support.
Independents Join Major Retailers in Gaining Access to COVID-19 Vaccine
AmerisourceBergen has reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC) to include Good Neighbor Pharmacy and the Elevate Provider Network members in the Federal Pharmacy Partnership Strategy for COVID-19 Vaccination.
To support access, AmerisourceBergen will serve as a network administrator and place orders with the CDC on behalf of qualified and eligible Good Neighbor Pharmacy and Elevate Provider Network members. AmerisourceBergen will receive a direct allocation of COVID-19 vaccine for independent retail pharmacy customers once there is adequate supply of COVID-19 vaccine to support broader vaccination efforts. COVID-19 vaccine will be distributed by the CDC’s central distributor.
“Independent community pharmacies have been fearless and have risen to every challenge that COVID-19 has presented this past year. Independent pharmacies are critical sites of care in their communities year-round and many Americans turn to their local pharmacy for a variety of immunizations annually,” said Brian Nightengale, President of Good Neighbor Pharmacy. “We are beyond proud to help our independent pharmacies gain access to COVID-19 vaccine. They are already poised to join this next phase in the fight against the coronavirus and continue to support their communities.”
This effort will help jurisdictions augment access to COVID-19 vaccine when supply increases and vaccination is recommended for individuals beyond the initial critical populations. With more than 90% of people living within 5 miles of a community pharmacy, pharmacies have unique reach and ability to provide access to COVID-19 vaccine and support broad vaccination efforts. This program will provide critical vaccination services for the U.S. population, with vaccine administered at community pharmacy locations at no cost to recipients. The program will be implemented in close coordination with jurisdictions to ensure optimal COVID-19 vaccination coverage and vaccine access nationwide.
COVID-19 Signage Available on Good Neighbor Pharmacy Signage Portal
Temporary signage is now available to meet the changing needs of your business. Sneeze guards, distancing dots, window clings, sidewalk signs and much more can be found on the Good Neighbor Pharmacy signage portal.
Communications and Tools for Good Neighbor Pharmacy and Elevate members
-
One-Time Call/Text Campaign: Keep your patients updated and provide them with information about how your pharmacy can assist them. For more information, download COVID-19 Campaigns from PrescribeWellness. To get started on your patient update, log into your Patient Engagement Center.
-
COVID-19 Resources tab in your Patient Engagement Center
-
AmerisourceBergen Customer Letter and FAQ
-
AmerisourceBergen Customer Townhall Recording (Hosted 10/6/20)
-
AmerisourceBergen Customer Townhall Recording (Hosted 11/10/20)
-
AmerisourceBergen Customer Townhall Recording (Hosted 12/8/20)
Additional Resources for Good Neighbor Pharmacy Members
-
Social media graphics and print marketing materials to educate patients
-
Promotions and collateral to raise awareness of the helpful services you offer
-
Tips for staying healthy and safe
My GNP Mobile App
Provide patients with an additional method of refilling prescriptions with the My GNP mobile app. Leveraging the mobile app will reinforce social distancing and help alleviate high volume of calls to your pharmacy.
The My GNP mobile app can be found by searching "My GNP" on the Google Play or Apple App store.
Financial Resources
BD Veritor™ Plus System (SARS-CoV-2 Test) Test Kits to Be Available from AmerisourceBergen
The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19.